Affiris Develops Alzheimer's Vaccine
The Viennese biotech company Affiris is taking stock of the progress achieved to date in its clinical Alzheimer's vaccination programme. All the Alzheimer's patients treated so far as part of the toxicological trials have tolerated the treatment extremely well.
Antioxidant Therapy Shows Early Promise Against Alzheimer's Disease - Improved Blood Flow Boosted Cognition And Behavior In Mice With AD-Like Illness
For the first time, new research demonstrates that curbing harmful antioxidant processes in the brain's vasculature can reverse some of the cognitive decline associated with Alzheimer's disease. A natural enzyme of the immune system -- NADPH oxidase -- has been found to have toxic side effects, producing free radicals in the brains of mice.
Alzheimer's Society Comment On Reducing Your Risk Of Developing Dementia, UK
It is important that people lead a healthy lifestyle to reduce their risk of developing dementia. This research adds to the weight of evidence on drinking and smoking habits and the risk of developing dementia. Smoking, drinking heavily and having high cholesterol can all lead to an increased risk of developing this devastating condition and the risk is further increased for individuals with a particular genetic variant.
PHC's Pivotal Research Initiates Largest Phase I Alzheimer's Disease Trial To Date For Major National Sponsor
PHC, Inc. (AMEX: PHC) d.b.a. Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services and pharmaceutical research, reported that its Pivotal Research Centers has initiated its largest Phase I Alzheimer's Disease trial to date for a major national sponsor.
Alzheimer's Foundation Of America Symposium: Identifying Young-Onset Alzheimer's Disease
They are too young to forget the faces of loved ones. They are too young for missed appointments and shattered memories. They are too young for Alzheimer's disease. But maybe not. While Alzheimer's has long been associated with old age, new evidence is mounting that the disease can and does appear in mid-life, though it is rare.
Researchers Close In On Origins Of Alzheimer's Plaques
The ability of brain cells to take in substances from their surface is essential to the production of a key ingredient in Alzheimer's brain plaques, neuroscientists at Washington University School of Medicine in St. Louis have learned.The researchers used a drug to shut down the intake process, known as endocytosis, in a mouse model of Alzheimer's disease.
PharmAthene's Recombinant Butyrylcholinesterase rBChE May Play A Neuroprotective Role In Alzheimer's Disease
PharmAthene, Inc. (Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced that scientists from the Hebrew University of Jerusalem, one of PharmAthene's collaboration partners, have recently obtained new data suggesting that recombinant butyrylcholinesterase (rBChE), a non-pegylated form of Protexia(R), may have neuroprotective benefits.
Alzheimer's And Intelligence
"Fish oil brain boost, " is the headline in the Daily Mail. The paper says that a "breakthrough in the battle against Alzheimer's is being claimed by British scientists who believe it can be fought with omega-3 oils". The newspaper adds that "older people whose diets are rich in omega-3 oils do better in mental tests than those without the oils in their diets".
Three Researchers Awarded AAN Potamkin Prize For Alzheimer's Research
The American Academy of Neurology (AAN) is awarding the 2008 Potamkin Prize to three researchers for their work in Alzheimer's disease research. Clifford R. Jack Jr., MD, of the Mayo Clinic, and William E. Klunk, MD, PhD, and Chester A. Mathis, PhD, both with the University of Pittsburgh School of Medicine, will receive the award during the AAN's 60th Annual Meeting in Chicago, held April 12-19, 2008.
The Effects Of Caffeine On Alzheimer's Disease - NHS Reaction
"A cup of coffee a day could keep Alzheimer's at bay, " says the Daily Mail. It reports that scientists have found that caffeine protects the brain from the harmful effects of high cholesterol, which they say is a risk factor for Alzheimer's. It explains that previous studies have suggested that cholesterol can cause 'leaks' in the 'blood-brain barrier', which protects the brain from harmful substances in the bloodstream.